Clinical Trials Browser

Phase 2 × Neoplasm Metastasis × apalutamide × Clear all

NCT03098836 2025-09-12

PANTHER

Phase 2 Completed

93 enrolled 17 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT05422911 2022-06-21

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

Phase 2 Not yet recruiting

Neoplasm Metastasis, Prostatic Neoplasms